NCT04496349 2025-11-04A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLAscentage Pharma Group Inc.Phase 2 Recruiting78 enrolled
NCT03873493 2022-12-19A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic LeukemiaAbbViePhase 2 Completed14 enrolled 19 charts